IRF4 and breast cancer: In stark contrast, while C29 and 5-azadC inhibited cell proliferation, this effect was demonstrated to be IRF4-dependent as shRNA-mediated suppression of IRF4 could significantly restore cell growth capabilities, underscoring an anti-proliferative function of IRF4 in BC cells (Fig. 7c).